SCM
TDOC icon

Silvant Capital Management’s Teladoc Health TDOC Stock Holding History

Silvant Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,715
Closed -$701K – 339
2022
Q1 		$701K Sell
9,715
-119
-1% -$8.57K 0.13% 103
2021
Q4 		$903K Sell
9,834
-434
-4% -$51.9K 0.15% 98
2021
Q3 		$1.3M Sell
10,268
-2,038
-17% -$297K 0.23% 82
2021
Q2 		$2.05M Sell
12,306
-210
-2% -$34K 0.32% 76
2021
Q1 		$2.27M Sell
12,516
-343
-3% -$79.6K 0.39% 67
2020
Q4 		$2.57M Sell
12,859
-233
-2% -$47.4K 0.44% 61
2020
Q3 		$2.87M Buy
13,092
+2,445
+23% +$518K 0.54% 48
2020
Q2 		$2.03M Sell
10,647
-690
-6% -$121K 0.37% 75
2020
Q1 		$1.76M Sell
11,337
-213
-2% -$24.8K 0.38% 72
2019
Q4 		$967K Buy
+11,550
New +$879K 0.18% 98

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Silvant Capital Management's TDOC Position: Q2 2022 in Review

Silvant Capital Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 9,715 shares — an estimated $701K sold.

Silvant Capital Management first reported a position in TDOC in Q4 2019 and held it in 10 quarters. The position peaked at $2.87M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Silvant Capital Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Silvant Capital Management sold 9,715 Teladoc Health shares in Q2 2022, an estimated $701K.
  • Silvant Capital Management first reported a position in Teladoc Health in Q4 2019 and held it in 10 quarters.
  • Silvant Capital Management's Teladoc Health position peaked at $2.87M in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Silvant Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.